- $90.02m
- $83.20m
- $2.14m
Annual cashflow statement for Nutriband, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.93 | -6.18 | -4.48 | -5.49 | -10.5 |
| Depreciation | |||||
| Non-Cash Items | 2.36 | 3.6 | 1.39 | 1.45 | 5.54 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.12 | -0.541 | -0.219 | 0.223 | 0.034 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.297 | -2.81 | -2.99 | -3.53 | -4.63 |
| Capital Expenditures | — | -0.082 | -0.079 | -0.052 | -0.092 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.067 | 0 | — | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | 0.067 | -0.082 | -0.079 | -0.052 | -0.092 |
| Financing Cash Flow Items | -0.042 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.372 | 7.63 | 0.16 | 2.09 | 8.54 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.142 | 4.74 | -2.91 | -1.49 | 3.82 |